Advanced search
News (22)
Companies (13)
Veru Inc. is a biopharmaceutical company. The Company is focused on developing medicines for the for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the manag ...
Ard Grup Bilisim Teknolojileri AS is a Turkey-based information technology (IT) company. It focuses on architecture implementation, software development, and cyber security providing customizable products and services. Its offering includes a wide range o ...
MediciNova, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States market. It is focused on its development activiti ...
Talphera, Inc., formerly AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidate ...
Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company is engaged in discovering, developing, and delivering pharmaceutical therapies. It is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) ...
BioCardia, Inc. is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. It is advancing two cell therapy platforms derived from bone marrow such as CardiAMP autologous monon ...
Avalo Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The Company's lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. Its pipeline also includes quisovalimab (AVTX-0 ...
Mesoblast Limited is an Australia-based is developing a range of late-stage product candidates derived from its proprietary mesenchymal lineage cell therapy technology platforms. The Companyâs Remestemcel-L is mesenchymal lineage stromal cell product pl ...
Edesa Biotech, Inc. is a Canada-based clinical-stage biopharmaceutical company developing various ways to treat inflammatory and immune-related diseases. The Companyâs advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for ...
Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologi ...
Peak Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on commercializing therapeutics that aim to improve and address unmet medical needs for patients with inflammatory, rare and specialty diseases and cancer. The Companyâ ...
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain ...
Advanced Life Sciences Holdings, Inc. is a United States-based biopharmaceutical company. The Company is engaged in the discovery, development, and commercialization of drugs in the therapeutic areas of infection, cancer, and respiratory diseases. The Com ...
Insiders
Ms. Laure Frères is an Executive Vice President, Head-Quality & Medical at Orpea SA.
Currently, Laure Perréard holds the position of Chief Financial Officer of Tikehau Capital SCA.
Laure Duhot currently holds several positions as an Independent Non-Executive Director at Safestore Holdings Plc, NB Global Monthly Income Fund Ltd., Primary Health Properties Plc, and Non-Executive Director at Safestore Ltd.
She is also a Director at Lifestory Group Ltd.
and a Managing Director at Duhot-Consult Ltd.
In the past, she held positions as Managing Director at Grainger Plc from 2012 to 2016, Independent Non-Executive Director at MXF Fund Ltd., Independent Non-Executive Director at Inland Homes PLC from 2018 to 2020, Independent Director at Orpea SA from 2022 to 2023, and Non-Executive Director at Thames Valley Housing Association Ltd.
She also worked as Head-Investment & Capital Markets-Europe at Lendlease Group.
Laure Roberts Swift served as Vice President-Human Resources Europe at Air Products & Chemicals, Inc. She then worked as Head-Human Resources at Syngenta AG from 2011 to 2020.
She earned an MBA from the University of Aston in 1985 and completed her undergraduate degree at ESCP Europe Campus Paris.
Ms. Laure Penchinat is Secretary & Director at Société des Lecteurs du Monde SA. She is on the Board of Directors at Société des Lecteurs du Monde SA.
She received her undergraduate degree from the Institut National des Langues & Civilisations Orientales.
Laure Hauseux is currently a Director at Plastiques du Val de Loire SA, OGF SA, and an Independent Director at Maisons du Monde SA and Fnac Darty SA. She is also a Member-Supervisory Board at Pomona SA, a Member-Management Board at Obol France 1, and a Manager at Sci Le Nid.
In the past, she has worked as a Deputy Chief Executive Officer at Conforama Italia SpA, Chief Executive Officer at GAC SASU, Deputy Director General at Virgin Stores SA, Store Manager at Fnac Direct SASU, and Chief Financial Officer at Printemps SASU.
She has also served as an Independent Director at Casino, Guichard-Perrachon SA and Zodiac Aerospace SA. She holds an MBA from INSEAD and ESCP Europe, and an undergraduate degree from Université Paris Dauphine-PSL.
Laure Heriard-Dubreuil is the founder of 1220 Collins Avenue, Inc. She is currently the Chairman of Laure HD Investissements SAS and a Director at Rémy Cointreau SA. Ms. Heriard-Dubreuil has an undergraduate degree from the Fashion Institute of Technology and another undergraduate degree from the Institut National des Langues & Civilisations Orientales.
Ms. Laure Oriez is a Head of Compliance at Trusteam Finance SCA.
She joined the firm in 2013.
She was a discretionary portfolio manager at Compagnie Internationale de Banque before becoming a mutual fund manager in charge of fixed-income management and employee savings funds at Monte Paschi Banque from 1987.
In 2004, she became Deputy Director at Monte Paschi Invest in charge of regulatory and control matters, and then held the post of Managing Director from 2009 to 2012.
She is a chemical engineer by training (at the INSCI Rouen) and the holder of an MBA at EM Lyon (CESMA).
Ms. Laure Négiar, CFA, is an Analyst & Portfolio Manager at Comgest SA. She joined Comgest in 2010 and is an Analyst and Portfolio Manager specialising in Global equities.
She is also a non-executive member of the Board of Partners and the Global Equity Team manager.
She co-manages Comgest's Global and EAFE (Global ex-US) strategies as well as the team’s segregated accounts.
Before joining Comgest, she worked at BNP Paribas Equities & Derivatives in Paris and London, and prior to that worked in several roles within the US government.
She obtained a Bachelor’s degree in Public Policy from Stanford University (with Honours and Phi Beta Kappa) before graduating on the Dean's list with an MSc in Management from the HEC business school in France.
Laure Chevrillon has worked as an Investment Manager at Chevrillon & Associés SCA since 2015.
Laure Fau currently works as a Director at Famille Mommessin SA.
Laure Morsy is currently a Director at BNP Paribas UK Holdings Ltd.
and BNP Paribas Lease Group SA Zweigniederlassung Deutschland.
Previously, Mr. Morsy worked as the Chief Operating Officer & Head-Corporate Banking at BGL BNP Paribas SA.
Laure Levin currently works at Modular Robotics, Inc., as Vice President-Sales.
Laure Genet worked as an Analyst at SG Securities (Paris) SAS from 2011 to 2016.
She also worked as an Analyst at Société Générale SA (Broker).
Marjan Laure currently works as a Sales Manager at ES Energy Save Holding AB.
Laure Carladous currently holds the position of Chairman at Société Travaux Constructions Materiaux.
She is currently working as a Director at Société Mutuelle d'Assurance du BTP, where she started in 2020.
Laure Poty worked as a Director of Group Communications at ID Logistics Group.
Laure Delaquaize is associated with three different organizations.
She is currently serving as the Chairman of Cl de Melun and Vice Chairman of Association Point Passerelle.
In addition, she is also working as a Director at Caisse Régionale De Crédit Agricole Mutuel Brie Picardie since 2019.
Laure Canivet Donsimoni has worked as a Credit Portfolio Manager at Amundi Asset Management SA (Investment Management) since 2014.
Laure Fouin currently works at McCarthy Tétrault LLP ( Canada), as Partner.
Laure Michel is currently a Director at McPhy Energy SA, Nenuphar SA, Technologgia SAS, NAWATechnologies SA, Apix Analytics SA, eLichens SAS, Pili SAS, DCbrain SAS, and Green Impulse SAS.
She is a former Chief Executive Officer at Secant, Inc. Michel has an undergraduate degree from Université Pierre et Marie Curie and another undergraduate degree from Institut d’Administration des Entreprises.
Laure Hurbin has worked as a Director at Nexans Maroc SA since 2016.
Laure Arnon-Duquesnoy is currently a Partner at August & Debouzy.
Laure Geffroy has a current job as Director of Human Resources at Bio-UV Group SA.
Laure Muneret currently works at Mon Courtier Energie Groupe SA, as Manager-Customer Service.
Laure Belluzzo is currently the Chairman at Progica, and a Director at both CA Consumer Finance SA and Crédit Agricole Consumer Finance SA. Previously, he was the Head-Audit at Crédit Lyonnais SA from 2008 to 2016.
Laure Desbrosses is a Senior Credit analyst at LBP AM since 2022.
Prior to this, she worked as a Senior Credit Analyst at Allianz Global Investors GmbH (France) from 2013 to 2021.
Before that, she was a Research Analyst at Oddo BHF SCA (Broker) from 2011 to 2012.
Additionally, she worked as a Vice President at CBAM SAS in 2022.
No results for this search
- Stock Market
- Advanced search
- Laure Perr�ard